Combination therapy for a ras related disease or disorder
US-2026053798-A1 · Feb 26, 2026 · US
This page is not indexed by search engines while we improve data quality.
Seamon Kyle patents
Seamon Kyle is listed as an inventor on 35 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Seamon Kyle |
| Total patents | 35 |
| First publication | Mar 31, 2020 |
| Latest publication | Feb 26, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Methods for inhibiting ras
US-2024277796-A1 · Aug 22, 2024 · US
Cascade/dCas3 Complementation Assays for In Vivo Detection of Nucleic Acid-Guided Nuclease Edited Cells
US-2022267747-A1 · Aug 25, 2022 · US
Cascade/dCas3 complementation assays for in vivo detection of nucleic acid-guided nuclease edited cells
US-11359187-B1 · Jun 14, 2022 · US
Cascade/dCas3 Complementation Assays for In Vivo Detection of Nucleic Acid-Guided Nuclease Edited Cells
US-2022177865-A1 · Jun 9, 2022 · US
Engineered enzymes
US-11345903-B2 · May 31, 2022 · US
Cascade/dCas3 complementation assays for in vivo detection of nucleic acid-guided nuclease edited cells
US-11286471-B1 · Mar 29, 2022 · US
Cascade/dCas3 Complementation Assays for In Vivo Detection of Nucleic Acid-Guided Nuclease Edited Cells
US-2022073892-A1 · Mar 10, 2022 · US
Novel mad nucleases
US-2022049233-A1 · Feb 17, 2022 · US
Cascade/dCas3 complementation assays for in vivo detection of nucleic acid-guided nuclease edited cells
US-11198857-B2 · Dec 14, 2021 · US
Recent patents
Latest publications not already listed above.
Mad nucleases
US-11193115-B2 · Dec 7, 2021 · US
Cascade/dCas3 Complementation Assays for In Vivo Detection of Nucleic Acid-Guided Nuclease Edited Cells
US-2021355467-A1 · Nov 18, 2021 · US
Mad nucleases
US-11174471-B2 · Nov 16, 2021 · US
Novel mad nucleases
US-2021324355-A1 · Oct 21, 2021 · US
Novel mad nucleases
US-2021301270-A1 · Sep 30, 2021 · US
Cascade/dCas3 complementation assays for in vivo detection of nucleic acid-guided nuclease edited cells
US-11104890-B1 · Aug 31, 2021 · US
MAD nucleases
US-11085030-B2 · Aug 10, 2021 · US
MAD nucleases
US-11053485-B2 · Jul 6, 2021 · US
Novel mad nucleases
US-2021198641-A1 · Jul 1, 2021 · US
Novel mad nucleases
US-2021171923-A1 · Jun 10, 2021 · US
Engineered enzymes
US-2021155912-A1 · May 27, 2021 · US
Cascade/dCas3 complementation assays for in vivo detection of nucleic acid-guided nuclease edited cells
US-11008557-B1 · May 18, 2021 · US
Mad nucleases
US-10883095-B1 · Jan 5, 2021 · US
Engineered enzymes
US-10876102-B2 · Dec 29, 2020 · US
Nucleic acid-guided nucleases
US-10870841-B1 · Dec 22, 2020 · US
Engineered enzymes
US-2020354703-A1 · Nov 12, 2020 · US
Nucleic acid-guided nucleases
US-10767169-B1 · Sep 8, 2020 · US
Nucleic acid-guided nucleases
US-10745678-B1 · Aug 18, 2020 · US
Nucleic acid-guided nucleases
US-10724021-B1 · Jul 28, 2020 · US
Nucleic acid-guided nucleases
US-10704033-B1 · Jul 7, 2020 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Inscripta Inc | 33 |
| Revolution Medicines Inc | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C12N9/22 | 33 |
| C12N2310/20 | 24 |
| C12N15/102 | 24 |
| C12N2800/80 | 19 |
| C12N15/113 | 19 |